Quarterly report [Sections 13 or 15(d)]

Stock-Based Compensation

v3.25.1
Stock-Based Compensation
 3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation

9. Stock-Based Compensation

There have been no material changes to the terms of our various equity incentive plans since the filing of our Annual Report on Form 10-K. Refer to Note 13, “Stock-Based Compensation,” in our Annual Report on Form 10-K filed with the SEC on March 31, 2025 for more information.

Stock-Based Compensation

Compensation costs that have been included in our condensed consolidated statements of operations and comprehensive loss for all stock-based compensation arrangements is set forth below:

 

 

 

Three months ended March 31,

 

Stock-based compensation

 

2025

 

 

2024

 

Cost of revenues

 

$

15

 

 

$

45

 

Sales and marketing

 

 

8

 

 

 

14

 

General and administrative

 

 

67

 

 

 

556

 

Research and development

 

 

(4

)

 

 

15

 

Total stock-based compensation

 

$

86

 

 

$

630

 

 

As of March 31, 2025, there was approximately $517 of total unrecognized compensation cost related to our stock benefit plans. These unrecognized compensation costs are expected to be recognized over an estimated weighted-average period of approximately 1.29 years.

Restricted Stock Units

A summary of our restricted stock unit activity for the three months ended March 31, 2025 is set forth below:

 

 

 

Shares

 

 

Weighted
Average Grant
Date Fair Value

 

Outstanding as of December 31, 2024

 

 

38,420

 

 

$

23.01

 

Granted

 

 

-

 

 

 

-

 

Released

 

 

-

 

 

 

-

 

Forfeited

 

 

(3,000

)

 

 

14.00

 

Outstanding as of March 31, 2025

 

 

35,420

 

 

$

23.77

 

Stock Options

A summary of our stock option activity under the 2018 Equity Incentive Plan (the “2018 Plan) and related information is as follows:

 

 

 

Number of
Shares

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term (years)

 

Aggregate
Intrinsic
Value

 

Outstanding as of December 31, 2024

 

 

2,500

 

 

$

56.89

 

 

 

 

 

 

Granted

 

 

-

 

 

 

-

 

 

 

 

 

 

Exercised

 

 

-

 

 

 

-

 

 

 

 

 

 

Forfeited

 

 

(1,500

)

 

$

38.15

 

 

 

 

 

 

Outstanding as of March 31, 2025

 

 

1,000

 

 

$

85.00

 

 

7.36

 

$

-

 

Exercisable as of March 31, 2025

 

 

1,000

 

 

$

85.00

 

 

7.36

 

$

-

 

A summary of our option activity under our 2009 Equity Incentive Plan (the “2009 Plan”) and related information is as follows:

 

 

 

Number of
Shares

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term (years)

 

Aggregate
Intrinsic
Value

 

Outstanding as of December 31, 2024

 

 

1,190

 

 

$

91.61

 

 

 

 

 

 

Granted

 

 

-

 

 

 

-

 

 

 

 

 

 

Exercised

 

 

-

 

 

 

-

 

 

 

 

 

 

Forfeited

 

 

-

 

 

0

 

 

 

 

 

 

Outstanding as of March 31, 2025

 

 

1,190

 

 

$

91.61

 

 

2.25

 

$

-

 

Exercisable as of March 31, 2025

 

 

1,190

 

 

$

91.61

 

 

2.25

 

$

-

 

Our stock benefit plans had 1,232,332 and 220,006 shares of common stock reserved for future issuances under our equity incentive plans as of March 31, 2025 and December 31, 2024, respectively. In addition, the shares of common stock reserved for issuance under the 2018 Plan also will include any shares of common stock subject to stock options granted under the 2009 Plan, that expire or otherwise terminate without having been exercised in full and shares of common stock issued pursuant to awards granted under the 2009 Plan that are forfeited. As of March 31, 2025, the maximum number of shares of common stock that may be added to the 2018 Plan pursuant to the foregoing is 1,190.

Furthermore, there were 63,167 and 46,791 shares of common stock available for sale and reserved for issuance under our 2018 Employee Stock Purchase Plan as of March 31, 2025 and December 31, 2024, respectively.